Abstract
Abstract The United States Government has sought to incentivize the development of medical countermeasures for biological agents (as well as other weapons of mass destruction) by establishing the Biomedical Advanced Research and Development Authority (BARDA). Several legal impediments exist to the development of vaccines targeting the most disconcerting biological agents. This paper identifies the key legal incentives and impediments regarding the development of vaccines for select agents and determine whether these incentives currently outweigh the impediments.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Biosecurity, Biosafety, and Biodefense Law
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
